Kentucky, Purdue Pharma Reach $24 Million Settlement in OxyContin Case

The Kentucky Attorney General’s Office has reached a $24 million settlement with Purdue Pharma over allegations that the drug company falsely marketed OxyContin, misrepresenting or concealing the opioid’s highly addictive nature. Under the agreement, Kentucky will receive a payment of $12 million within 30 days, including $1.5 million that will be paid as restitution to the state Medicaid agency. The remaining $12 million will be paid in annual installments over the next eight years. The money will be placed in a restricted fund for the General Assembly to use for drug addiction p...